Sana Biotechnology (SANA) Non-Current Assets (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Non-Current Assets data on file, last reported at $261.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 21.29% year-over-year to $261.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 21.38% YoY), and the FY2025 full-year result was $268.2 million, down 21.16% from the prior year.
• Non-Current Assets slipped to $261.9 million in Q1 2026, from $268.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $524.4 million in Q1 2022 to a low of $261.9 million in Q1 2026.
• A 5-year average of $355.7 million and a median of $351.9 million in 2023 frame the typical range for Non-Current Assets.
• Peak annual rise in Non-Current Assets reached 55.61% in 2022, while the deepest fall reached 35.82% in 2022.
• Tracing SANA's Non-Current Assets over 5 years: stood at $378.3 million in 2022, then declined by 7.01% to $351.8 million in 2023, then declined by 3.29% to $340.2 million in 2024, then slipped by 21.16% to $268.2 million in 2025, then declined by 2.35% to $261.9 million in 2026.
• Business Quant data shows SANA's Non-Current Assets at $261.9 million in Q1 2026, $268.2 million in Q4 2025, and $273.7 million in Q3 2025.